Methadone/Opiate Rehabilitation and Education Center (MORE) - Louisville Kentucky

Methadone/Opiate Rehabilitation and Education Center (MORE) - Louisville, KY

Methadone/opiate Rehabilitation And Education Center more is treatment facility located at 4500 Churchman Avenue, Suite 300 in the 40215 zip code in Louisville, KY that offers medication assisted treatment for addiction. Methadone/opiate Rehabilitation And Education Center more provides methadone maintenance to adults and young adults. Some of the treatment approaches used by Methadone/opiate Rehabilitation And Education Center more consist of brief intervention, cognitive behavioral therapy and contingency management/motivational incentives.

Address: 4500 Churchman Avenue, Suite 300, Louisville, KY 40215

1. Types of Care
2. Service Settings
3. Opioid Medications used in Treatment
4. Type of Alcohol Use Disorder Treatment
5. Type Of Treatment
6. Pharmacotherapies
7. Treatment Approaches
8. FacilityOwnership
9. License/Certification/Accreditation
10. Payment/Insurance/Funding Accepted
11. Assessment/Pre-treatment
12. Screening & Testing
13. Transitional Services
14. Ancillary Services
15. Counseling Services and Education
16. Medical Services
17. Tobacco/Screening Services
18. Facility Smoking Policy
19. Age Groups Accepted
20. Gender Accepted
21. Exclusive Services
22. Services for deaf

Here are the full facility listing details on Methadone/Opiate Rehabilitation and Education Center (MORE) in Louisville, KY:

Phone #: 502-574-6414

Is Methadone a safe option for addiction treatment?

Methadone treatment can be a safe and effective option for individuals struggling with opioid addiction, especially when administered under the supervision of a qualified healthcare provider as part of a comprehensive addiction treatment program, such as the one that can be found at Methadone/Opiate Rehabilitation and Education Center (MORE). Methadone is an opioid medication that is used to help manage opioid withdrawal symptoms and cravings, making it easier for individuals to reduce or quit their use of other opioids like heroin or prescription painkillers.

Here are some key points to consider regarding the safety of methadone treatment:

1. Supervised Administration: Methadone treatment is typically provided through opioid treatment programs (OTPs) or clinics where patients receive a daily dose of methadone under the supervision of healthcare professionals. This helps reduce the risk of misuse and overdose.

2. Reduces Withdrawal Symptoms: Methadone can alleviate the severe withdrawal symptoms associated with opioids, which can be a significant barrier to recovery. This can enhance the patient's quality of life and make it easier for them to engage in therapy and counseling.

3. Harm Reduction: Methadone maintenance treatment can be viewed as a harm reduction approach. While it doesn't necessarily lead to immediate abstinence, it reduces the risks associated with illicit opioid use, such as overdose and the transmission of infectious diseases (e.g., HIV and hepatitis).

4. Individualized Treatment: Methadone treatment should be individualized to meet the unique needs of each patient. The dose is typically adjusted based on the patient's response and progress in treatment.

5. Legal Regulation: Methadone clinics and providers are subject to strict regulations and oversight by government agencies to ensure safety and appropriate use of the medication.

However, it's important to note that methadone is an opioid itself and can be habit-forming. When taken as prescribed and under medical supervision, the risk of addiction to methadone is relatively low. However, misuse or diversion of methadone can lead to addiction and other negative consequences.

Methadone treatment is not suitable for everyone. Individuals with certain medical conditions or contraindications may not be candidates for methadone treatment. It's essential for addiction treatment centers like Methadone/Opiate Rehabilitation and Education Center (MORE) to conduct a thorough assessment before starting someone on methadone.